Evidence that LDL receptor-related protein 1 acts as an early injury detection receptor and activates c-Jun in Schwann cells

Neuroreport. 2016 Dec 14;27(18):1305-1311. doi: 10.1097/WNR.0000000000000691.

Abstract

Schwann cells (SCs) detect injury to peripheral nerves and transform phenotypically to respond to injury and facilitate repair. Cell-signaling pathways and changes in gene expression that drive SC phenotypic transformation in injury have been described; however, the SC receptors that detect peripheral nervous system (PNS) injury have not been identified. LDL receptor-related protein 1 (LRP1) is a receptor for numerous ligands, including intracellular proteins released by injured cells and protein components of degenerated myelin. In certain cell types, including SCs, LRP1 is a cell-signaling receptor. Here, we show that binding of the LRP1 ligand, tissue-type plasminogen activator (tPA), to cultured rat SCs induces c-Jun phosphorylation, a central event in activation of the SC repair program. The response to tPA was blocked by the LRP1 antagonist, receptor-associated protein. c-Jun phosphorylation was also observed when cultured rat SCs were treated with a recombinant derivative of matrix metalloproteinase-9 that contains the LRP1 recognition motif (PEX). The ability of LRP1 to induce c-Jun phosphorylation and ERK1/2 activation was confirmed using cultures of human SCs. When tPA or PEX was injected directly into crush-injured rat sciatic nerves, c-Jun phosphorylation and ERK1/2 activation were observed in SCs in vivo. The ability of LRP1 to bind proteins released in the earliest stages of PNS injury and to induce c-Jun phosphorylation support a model in which SC LRP1 functions as an injury-detection receptor in the PNS.

MeSH terms

  • Animals
  • Animals, Newborn
  • Cells, Cultured
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects
  • LDL-Receptor Related Protein-Associated Protein / pharmacology
  • Low Density Lipoprotein Receptor-Related Protein-1 / metabolism*
  • Matrix Metalloproteinase 9 / pharmacology
  • PHEX Phosphate Regulating Neutral Endopeptidase / pharmacology
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-jun / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Schwann Cells / drug effects
  • Schwann Cells / metabolism*
  • Sciatic Nerve / cytology
  • Sciatic Neuropathy / drug therapy
  • Sciatic Neuropathy / metabolism*
  • Signal Transduction / drug effects
  • Time Factors
  • Tissue Plasminogen Activator

Substances

  • LDL-Receptor Related Protein-Associated Protein
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Proto-Oncogene Proteins c-jun
  • Tissue Plasminogen Activator
  • PHEX Phosphate Regulating Neutral Endopeptidase
  • PHEX protein, human
  • Matrix Metalloproteinase 9